Archive of Newsletters
|
| Minutes |
SSPD Business Meeting in Miami
Beach, Florida October 26, 1999 |
|
The meeting was called to order by the current president,
Charles France, at 5:30 p.m. The first order of business was consideration
of nominations for the next president-elect. Volunteers were sought
and by the time the ballot was mailed, we had the required three
nominees: Patrick Beardsley, David Gauvin, and Joe Porter.
The next order of business was review of the progress
of SSPD over the last year and plans for the future. Charles summarized
highlights of our well-attended meetings at Neuroscience in Los
Angeles (in November 1998) and at the BPS/EBPS meeting in Boston
(September 1999). Given the success of the dual-meeting format this
year, discussion turned to the possibility of continuing to have
two meetings next year. Sentiment remained high that the Neuroscience
SSPD session should stay. A second meeting in conjunction with the
ASPET meeting in Boston was proposed. Advantages of SSPD sponsorship
of a session at this meeting would include positive support for
the new Behavioral Pharmacology section of ASPET and enhanced visibility
of the organization to pharmacologists not directly involved in
the study of the stimulus properties of drugs. In addition, the
BPS is meeting in Boston immediately prior to ASPET. A motion was
made for SSPD to support a session at the ASPET meeting and was
unanimously approved. (See additional details in this newsletter.)
Membership issues were next on the agenda. I initiated
a discussion of how to handle membership/database for members who
had not paid their dues for a number of years, particularly those
for whom the address listed in the database was uncertain. Jim Woods
expressed concern that inactive, but interested, individuals might
be dropped from the membership. Others expressed concern about the
impact of this on international members not in the USA. A motion
was made to drop past members from the rolls upon failure to pay
their dues for two consecutive years. I reiterated that the major
purpose of the proposal was to develop a mechanism through which
to purge the database of former members for whom contact information
and continued interest was uncertain. The motion was passed unanimously.
Charles encouraged attendees to get the membership growing by stimulating
new members, particularly students and young scientists, to join.
The Treasurer's report was next (see next page). SSPD
is in a healthy financial position as the result of reliable and
generous donations from industry given as an expression of support
for our organization. A list of companies that have made recent
donations to SSPD is given on page 4 of this newsletter.
TREASURER'S REPORT (12/31/98 - 10/22/99)
|
Beginning Balance 12/31/98
|
5656.44
|
| Expenses |
| Postage |
74.00
|
|
| 1998 Neuroscience meeting fees |
544.63
|
| 1999 Neuroscience program listing |
135.00
|
| Bank charges |
25.99
|
| Web page design |
250.00
|
|
1029.62
|
| Income |
| Donations |
2950.00
|
|
| Dues |
310.00
|
|
|
3260.00
|
|
Balance as of 10/22/99
|
7886.82
|
Following the Treasurer's report, Charles formally
introduced our new Web site (http://www.sspd.org.uk/). As mentioned
in the last newsletter, this site was designed and has been maintained
by Ian and Dominic Stolerman. During the meeting, we discussed issues
related to registration and continued maintenance of the site. Although
several options were proposed, there was general agreement that
SSPD should register its own name (SSPD.ORG.UK). In addition, a
proposal was made and accepted for Dominic to continue to manage
the site for $30/hr, with Ian supervising and reviewing items before
they are placed on the site. This situation will be reviewed at
the next Neuroscience session in the fall of 2000.
The scientific session began following adjournment
of the business meeting and refilling of drinks. We had four presenters,
with plenty of lively questions and debate following each talk.
Talk titles and presenters are listed below.
- The antagonist actions of beta-funaltrexamine on the high-dose
discriminative stimulus effects of fentanyl and morphine in rats.
M. Evola, S.E. Bowen, and A.M. Young, Wayne State University,
Detroit, MI
- Discriminative stimulus effects of centrally administered isoproterenol.
A. Crissman, Louisiana State University Health Science Center,
Shreveport, LA
- Drug discrimination with antipsychotic drugs: past, present
and future? J.H. Porter, Virginia Commonwealth University, Richmond,
VA
- Tolerance, dependence and the stimulus functions of drugs. J.H.
Woods, University of Michigan, Ann Arbor, MI
The scientific session ended at 9:00 p.m
Jenny Wiley, Ph.D.
Secretary/Treasurer
|